Evidence Hub

Bone mineral density changes following immune checkpoint inhibitor therapy: insights from a case series analysis

Siampanopoulou V, Ziogas DC, Lyrarakis G, Anastasopoulou A, Kassi E, Gogas H, Angelousi A

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025

15 participants

Abstract

UNLABELLED: Brief rationale: The use of ICIs is increasing rapidly. Limited studies support potential effects on bone health.

MAIN RESULT: Osteoporotic patients demonstrated a 6% and 17% reduction in femoral and lumbar spine BMD, respectively. Paper significance: This is a real-world data record of the effect of one-year ICI treatment on skeletal health.

PURPOSE: Immune checkpoint inhibitors (ICIs) are used as a treatment for various malignancies, resulting in the occurrence of a plethora of immune-related adverse events (irAEs). An increasing interest has emerged on the possible effects of these drugs on the skeleton, predominantly osteoporotic fractures, although bone health studies are scarce.

METHODS: Our study analyzed retrospectively the percentage of the alteration of the bone mineral density (BMD) evaluated by Dual Energy X-Ray Absorptiometry (DXA) scan in 15 oncological patients before and after the administration of ICIs, as well as the occurrence of osteoporotic fractures, within a median follow-up period of 12 months.

RESULTS: Patients with normal baseline BMD presented a median femoral and lumbar BMD reduction of 0.15% and 0.10%, respectively. Patients with a baseline BMD in favor of osteopenia exhibited no alterations in the femoral BMD and a median 0.07% reduction in the lumbar BMD. Patients with baseline osteoporosis demonstrated a femoral and lumbar BMD reduction of 6% and 17.30%, respectively. No osteoporotic fracture was demonstrated during the median…

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 15 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free